Pax6-deficient lens epithelium fails to exit the cell cycle at
the lens equator and undergoes apoptosis.
(A-B′,E-F′) Antibody labeling of control (A,B) and
Pax6lox/lox;Mlr10 (E,F) lenses from E14.5 mouse embryos.
(A,E) Expression of Pax6 (red) and Ki67 (green) with co-expression in the lens
epithelium (LE) of Ki67 and Pax6 (A, yellow). Some Ki67- cells
express Pax6 (A′, arrowhead). In Pax6lox/lox;Mlr10,
Pax6- Ki67+ cells are detected in the transitional zone
(E′) and in the posterior lens (E, arrowhead). (B,F) Phosphohistone H3
(PH3, green) and BrdU (B,F, red) were detected in the
Pax6lox/lox LE up to the lens equator (arrow, B) but also
posterior to the lens equator in the Pax6lox/lox;Mlr10
lenses (F,F′) and in the posterior lens (F, arrowheads). (C)
Quantitative analysis reveals a significant increase in the percentage of
BrdU+ cells in Pax6lox/lox;Mlr10 lenses
(70.7±5.1% s.d.) as compared with the control LE (52.8±1.4%,
**P<0.001). The percentage of PH3+ cells is
not altered in the Pax6- LE (control 14.3±6.2%; mutant
14.7±4.1%). (D,G,G′) Cleaved caspase 3
(cCas3)-positive cells detected in the LE of
Pax6lox/lox;Mlr10 lenses (G,G′, red, arrowhead) but
not in the control E14.5 mouse embryo (D). Counterstaining is with DAPI
(blue). co, cornea; re, retina. Scale bar: 100 μm.